第 1 到 6 筆結果,共 6 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2017 | Urgency to treat patients with chronic hepatitis C in Asia | JIA-HORNG KAO ; Ahn S.H.; Chien R.-N.; Cho M.; Chuang W.-L.; Jeong S.-H.; CHEN-HUA LIU ; Paik S.-W. | Journal of Gastroenterology and Hepatology (Australia) | 19 | 18 | |
2 | 2022 | Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5 | CHEN-HUA LIU ; JIA-HORNG KAO | Hepatology International | 7 | 8 | |
3 | 2022 | Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection | CHEN-HUA LIU ; JIA-HORNG KAO | Diagnostics (Basel, Switzerland) | 1 | 1 | |
4 | 2014 | Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: Optimizing use of peginterferon alfa | CHEN-HUA LIU ; JIA-HORNG KAO | International Journal of Nanomedicine | 33 | 34 | |
5 | 2013 | IL28B genotype on HCV infection in Asia | CHEN-HUA LIU ; JIA-HORNG KAO | Current Hepatitis Reports | 3 | 0 | |
6 | 2023 | Acute hepatitis C virus infection: clinical update and remaining challenges | CHEN-HUA LIU ; JIA-HORNG KAO | Clinical and molecular hepatology | 6 | 5 |